• Tuesday, March 23, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST)
  • Thursday, March 25, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST)


Online, using zoom.us and live on Youtube


3D cell culture systems have recently emerged as promising tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding extracellular matrix (ECM).

In this webinar we will focus on BIOMIMESYS® Liver and will discuss about its different applications. This matrix has specific composition and stiffness close to liver ECM, to be in accordance with in vivo conditions for the culture of hepatocyte cell lines or primary human hepatocytes, and production of liver organoids derived from human induced pluripotent stem cells (hiPSCs).

Learning objectives

  • Using BIOMIMESYS® Liver as a relevant 3D cell culture model to develop organoids with an example of liver organoids derived from iPSCs
  • Using BIOMIMESYS® Liver to cultivate liver cell lines and primary human hepatocytes

Registration is closed

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.